Literature DB >> 2445320

Increased vertical axon numbers in cingulate cortex of schizophrenics.

F M Benes1, R Majocha, E D Bird, C A Marotta.   

Abstract

Data generated from an earlier study have suggested a model in which greater numbers of long, vertical, associative axons may occur in the anterior cingulate cortex of schizophrenic patients relative to control subjects. This hypothesis has now been tested using neuron-specific antibodies raised against the 200-kilodalton neurofilament subunit, a component of neuronal cytoskeleton, to immunostain axons of human postmortem cingulate cortex. A manual method for counting axons in the region of layer II and sublamina IIIA has been designed and applied blindly to parallel control and schizophrenic immunoprocessed specimens. The results show that there are 25% more vertical axons in the schizophrenic than in the control specimens. Preferentially higher numbers of both long vertical axons (62%) and axons associated with blood vessels (52%) have also been noted in the schizophrenic specimens. By contrast, the number of large-caliber horizontal axons was the same in the two groups; therefore, the greater number of vertical axons in schizophrenic specimens does not appear to represent a nonspecific effect. When these data are corrected for the effects of several confounding variables using analysis of covariance, the overall pattern of the results persists. These findings suggest the possibility that there might be an increase of associative inputs into the anterior cingulate cortex of schizophrenic patients, although it is not clear at present whether the differences noted, if replicative, may be primarily or perhaps only secondarily related to the disorder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445320     DOI: 10.1001/archpsyc.1987.01800230097015

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  25 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

2.  Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia.

Authors:  Alex Fornito; Murat Yücel; Stephen J Wood; Chris Adamson; Dennis Velakoulis; Michael M Saling; Patrick D McGorry; Christos Pantelis
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

Review 3.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

Review 4.  Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes.

Authors:  Heather C Brenhouse; Susan L Andersen
Journal:  Neurosci Biobehav Rev       Date:  2011-05-12       Impact factor: 8.989

5.  Altered intermediate filament expression in human neuroblastoma cells transformed by a growth-promoting agent derived from schizophrenic CSF.

Authors:  S Shirabe; W H Fang; J P Schwartz
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

6.  Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.

Authors:  J John Mann; Maria A Oquendo; Kalycia Trishana Watson; Maura Boldrini; Kevin M Malone; Steven P Ellis; Gregory Sullivan; Thomas B Cooper; Shan Xie; Dianne Currier
Journal:  Depress Anxiety       Date:  2014-05-27       Impact factor: 6.505

7.  Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.

Authors:  Meredith A Reid; Luke E Stoeckel; David M White; Kathy B Avsar; Mark S Bolding; N Shastry Akella; Robert C Knowlton; Jan A den Hollander; Adrienne C Lahti
Journal:  Biol Psychiatry       Date:  2010-06-08       Impact factor: 13.382

8.  Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia.

Authors:  P C Fletcher; C D Frith; P M Grasby; K J Friston; R J Dolan
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

9.  Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses?

Authors:  R F Squires; A Lajtha; E Saederup; M Palkovits
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

10.  Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

Authors:  R C Roberts; K A Barksdale; J K Roche; A C Lahti
Journal:  Schizophr Res       Date:  2015-07-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.